Translational Expertise Quantigen operates as both a CRO and diagnostic lab with a cross-disciplinary team, enabling end-to-end translational projects from bench to bedside. This includes diagnostic protocol optimization and biomarker development and validation, as well as early medical-device design collaboration. Target pharma and biotech partners for integrated translational programs and companion diagnostics.

Early-Phase Biomarkers They actively support early-phase clinical trials and biomarker work, offering protocol optimization and biomarker endpoints with validation. Opportunities exist to pitch bundled early-phase services to biotech startups, aiding regulatory readiness and companion diagnostics development.

Versiti Network Acquired by Versiti, Quantigen could leverage expanded diagnostics and transfusion medicine networks to cross-sell services, access broader client bases, and collaborate on disease-area programs with added patient sample ecosystems.

Regional Growth Indiana-based Quantigen has a growth trajectory with expansion history and capacity to scale services for Midwest biotech clusters. Focused regional outreach, local partnerships, and grant-enabled collaborations can accelerate CRO and diagnostic service scale.

Tech and Security The tech stack includes security training and enterprise platforms, suggesting data security readiness and potential for compliant data handling. Position offerings around secure data management, privacy controls, and IT integration for client lab-to-clinic data transfer.